Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Preskorn

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Pharmacotherapeutic profile of venlafaxineS Preskorn
International Clinical Psychopharmacology|June 1, 1994
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertralineS Preskorn
Journal of Psychopharmacology (Oxford, England)|February 3, 2012
The SSRIs: advantages, disadvantages and differencesR Lane, D Baldwin, S Preskorn
Toxicology and Applied Pharmacology|May 1, 1982
The effect of diethyldithiocarbamate on brain uptake of cadmiumL R Cantilena, G Irwin, S Preskorn, et al.
Psychiatry Research. Neuroimaging|January 27, 2016
Amygdala activity during autobiographical memory recall as a biomarker for residual symptoms in patients remitted from depressionKymberly D Young, Wayne C Drevets, Jerzy Bodurka, et al.
Archives of Neurology|August 1, 1993
Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effectsD K Ziegler, A Hurwitz, S Preskorn, et al.
Surgical Neurology|December 1, 1977
Progressive multifocal leukoencephalopathy presenting as focal mass lesion in the brainM E Cunningham, P R Kishore, S S Rengachary, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Pharmacotherapeutic profile of venlafaxineS Preskorn
International Clinical Psychopharmacology|June 1, 1994
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertralineS Preskorn
Journal of Psychopharmacology (Oxford, England)|February 3, 2012
The SSRIs: advantages, disadvantages and differencesR Lane, D Baldwin, S Preskorn
Toxicology and Applied Pharmacology|May 1, 1982
The effect of diethyldithiocarbamate on brain uptake of cadmiumL R Cantilena, G Irwin, S Preskorn, et al.
Psychiatry Research. Neuroimaging|January 27, 2016
Amygdala activity during autobiographical memory recall as a biomarker for residual symptoms in patients remitted from depressionKymberly D Young, Wayne C Drevets, Jerzy Bodurka, et al.
Archives of Neurology|August 1, 1993
Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effectsD K Ziegler, A Hurwitz, S Preskorn, et al.
Surgical Neurology|December 1, 1977
Progressive multifocal leukoencephalopathy presenting as focal mass lesion in the brainM E Cunningham, P R Kishore, S S Rengachary, et al.
Pageof 1